go back

Tumor Cell Drug Response Test, First Drug

Nebraska rates for HCPCS 81535

A laboratory test that keeps living cancer cells taken from a gynecologic tumor alive in culture and exposes them to a cancer drug to see how strongly the cells react. The reaction is reported as a score that helps the oncologist judge which drug is more likely to work against that particular tumor. This covers the first drug or drug combination tested.

Facilitymedian $1,259 · 10th–90th $347$2,8840%10%10th90th$1,259Professionalmedian $437 · 10th–90th $347$3,8020%10%20%10th90th$437$200.0$500.0$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1,148.15
Median
$1,513.56
Typical High
$2,884.03
Aetna
Setting
Professional
Modifier
Global
Typical Low
$380.19
Median
$436.52
Typical High
$3,801.89
BCBS
Setting
Facility
Modifier
Global
Typical Low
$446.68
Median
$602.56
Typical High
$1,548.82
BCBS
Setting
Professional
Modifier
Global
Typical Low
$630.96
Median
$891.25
Typical High
$954.99
Cigna
Setting
Professional
Modifier
Global
Typical Low
$660.69
Median
$1,122.02
Typical High
$1,380.38
Medica
Setting
Facility
Modifier
Global
Typical Low
$208.93
Median
$724.44
Typical High
$2,754.23
Medica
Setting
Professional
Modifier
Global
Typical Low
$245.47
Median
$346.74
Typical High
$630.96
Midlands
Setting
Professional
Modifier
Global
Typical Low
$1,202.26
Median
$1,202.26
Typical High
$1,202.26
United
Setting
Facility
Modifier
Global
Typical Low
$245.47
Median
$346.74
Typical High
$691.83
United
Setting
Professional
Modifier
Global
Typical Low
$331.13
Median
$346.74
Typical High
$630.96